Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million
05 août 2021 16h05 HE
|
Fluidigm Corporation
Base business rebounds. Promising early reception to 4th generation mass cytometry instrument. Services business achieves quarterly revenue record of $6.6 million. SOUTH SAN FRANCISCO, Calif., Aug. ...
BioNTech gibt Update zu Entwicklungsplänen für nachhaltige Lösungen gegen Infektionskrankheiten auf dem afrikanischen Kontinent
26 juil. 2021 10h00 HE
|
BioNTech SE
BioNTech will den ersten mRNA-basierten Impfstoff zur Malaria-Prävention entwickeln und plant den Start einer klinischen Studie bis Ende 2022 BioNTech prüft nachhaltige Lösungen für...
BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent
26 juil. 2021 10h00 HE
|
BioNTech SE
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022BioNTech is evaluating sustainable mRNA vaccine production capacities...
Der Kampf gegen Infektionskrankheiten auf dem afrikanischen Kontinent
23 juil. 2021 09h50 HE
|
BioNTech SE
Der afrikanische Kontinent kämpft gegen einen überproportional hohen Anteil der globalen Infektionskrankheiten. Die außerordentlichen wissenschaftlichen Fortschritte, die während der COVID-19-Pandemie...
Fighting Infectious Diseases on the African Continent
23 juil. 2021 09h50 HE
|
BioNTech SE
The African continent carries a disproportionately high share of the global infectious disease burden. The extraordinary scientific progress made during the COVID-19 pandemic gives hope in addressing...
Infectious Disease Market Value Predicted To Reach US$ 24.5 Billion By 2027 Covering COVID-19 Impact: Acumen Research And Consulting
14 mai 2021 11h17 HE
|
Acumen Research and Consulting
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- The Global Infectious Disease Market is expected to grow at a CAGR of around 5.7% from 2020 to 2027 and reach the market value of over US$ 24.5 Bn by...
Taconic Biosciences Launches New COVID-19 Mouse Model
29 avr. 2021 09h00 HE
|
Taconic Biosciences
RENSSELAER, N.Y., April 29, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This...
Fluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial Results
08 avr. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
IMMUTEP SECURES SECOND UNITED STATES PATENT GRANT FOR EFTILAGIMOD ALPHA IN COMBINATION WITH A PD-1 PATHWAY INHIBITOR
09 mars 2021 08h00 HE
|
Immutep Limited
Sydney, AUSTRALIA, March 09, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for...
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
18 févr. 2021 08h01 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that...